BiotechTube
Home/Regel Therapeutics/Stephen J. Farr, Ph.D.
SJ

Stephen J. Farr, Ph.D.

CEO & Chairman of the Board

Regel Therapeutics

Therapeutic Areas

NeurologyGenetic Disorders

Regel Therapeutics Pipeline

DrugIndicationPhase
RT101Dravet SyndromePreclinical
RT102SCN2A HaploinsufficiencyPreclinical

Leadership Team at Regel Therapeutics

JD
Jordane Dimidschstein, Ph.D.
President, COO & Board Member
KA
Kate Allaway, Ph.D.
VP of Research
View full Regel Therapeutics profile